Navigation Links
Stem Cell Pioneer Recognized for 20 Years of Discovery and Innovation
Date:11/20/2012

TUCSON, Ariz., Nov. 20, 2012 /PRNewswire/ -- Dr. David Harris, Professor of Immunology at the University of Arizona and a scientific pioneer in the field of stem cell banking, was the recipient of the Arizona BioIndustry Association™ (AZBIO) 2012 award for "20 Years of Discovery and Innovation". The annual AZBIO Awards is Arizona's premier bioscience event and was held at the Phoenix Convention Center.

Dr. Harris is a graduate of Wake Forest University, the leading center for stem cell regenerative medicine and tissue engineering in the world today.

In 1991, Dr. Harris became the first person to bank stem cells for future use.  He did so by banking his first child's cord blood stem cells. In 1992, Dr. Harris founded the Arizona Cord Blood Bank which later evolved to become the Cord Blood Registry™ [CBR], the largest cord blood stem cell bank in the world. Dr. Harris continues as Chief Science Officer at CBR.

In 2011, Dr. Harris founded AdiCyte™, an adult stem cell banking company preserving adipose-derived [mesenchymal] stem cells for future use in regenerative medicine and tissue engineering. Adipose tissue, the medical name for 'fat', is the richest source of mesenchymal stem cells in the human body.

"I believe adipose stem cells have enormous potential in regenerative medicine and healing" Harris said. "My vision is to enable people to bank their stem cells for later use in treatments. Adipose stem cells can differentiate into other tissues such as heart muscle, bone, cartilage, nerve and more. Already, doctors have had success in restoring function after a heart attack, and engineering new organs such as a bladder, trachea or new blood vessels using a patient's own stem cells."

The Arizona BioIndustry Association is comprised of member organizations in business, research, government, and other professions involved in biosciences. AZBio supports the members of the Arizona bioscience community by providing access to the key resources, connections, and information that support their objectives.

AdiCyte Incorporated is the leader in biobanking of adipose tissue for use in cosmetic, surgical, reconstructive and regenerative medical treatments. Patients can now bank their adipose tissue as a biological resource for emerging treatments. The company's laboratory and processing facility is located at the University of Arizona Health Sciences Center in Tucson, Arizona. www.adicyte.com

Contact:
Stephen Grant, Corporate Communications
650.678.4999
sgrant@adicyte.com


'/>"/>
SOURCE AdiCyte
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Space Research Institute Honors Senator Hutchison with Pioneer Award
2. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
3. Air Force Office of Scientific Research hosts nanotechnology pioneer
4. Dr. Michael Yaremchuk, Leading Performer of Custom-Designed Facial Implants, Pioneers Bespoke Plastic Surgery
5. Glencoe Software and The Journal of Cell Biology Pioneer Publishing of Massive, Ultra-Resolution Images
6. Researchers pioneer worlds first HIV/AIDS nanomedicines
7. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
8. Metabolex Gout Program Recognized in Windhovers Top 10 Most Interesting Projects to Watch
9. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
10. Machine Preservation Significantly Improves Kidney Transplant Survival Over 3 Years Compared to Traditional box of ice
11. Expanded Findings for FirstMarks Completed Clinical Study for Predicting Near-Term (2-3 Years) MI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):